TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer

MLA

Xianwei Zhang, et al. “TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer.” OncoTargets and Therapy, vol. 14, Oct. 2021, pp. 4967–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....afca271b93deb38d68692c96f2559cd9&authtype=sso&custid=ns315887.

APA

Xianwei Zhang, Ting-Yi Sun, Yang Xu, Ruili Yu, Xue Wu, Kaihua Liu, Lingfei Kong, Yuqian Shi, Yang Shao, & Zhen Li. (2021). TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer. OncoTargets and Therapy, 14, 4967–4978.

Chicago

Xianwei Zhang, Ting-Yi Sun, Yang Xu, Ruili Yu, Xue Wu, Kaihua Liu, Lingfei Kong, Yuqian Shi, Yang Shao, and Zhen Li. 2021. “TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer.” OncoTargets and Therapy 14 (October): 4967–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....afca271b93deb38d68692c96f2559cd9&authtype=sso&custid=ns315887.